Magnesium Boosts Environmental Enrichment in Alzheimer's

This article originally appeared here.
Share this content:
Magnesium Boosts Environmental Enrichment in Alzheimer's
Magnesium Boosts Environmental Enrichment in Alzheimer's

THURSDAY, Nov. 30, 2017 (HealthDay News) -- The combination of environmental enrichment (EE) and magnesium-L-threonate (MgT) is more effective than either treatment alone for improving cognition and spatial memory in a mouse model of Alzheimer's disease (AD), according to a study published online Nov. 10 in CNS Neuroscience & Therapeutics.

Ying Huang, from Tsinghua University in Beijing, and colleagues treated APP/PS1 mice with EE, MgT, or the combination of EE and MgT (EM), and compared the effect on memory function.

The researchers found that, compared with either treatment alone, EM was more effective in improving cognition and spatial memory in long-term (12 months; started at age 3 months, before disease manifestation) and short-term (three months; started at age 6 months, after manifestation of disease) treatment. The behavioral improvement corresponded with synaptic contact rescue in the AD mouse brain hippocampal region. EM rescued the activity reduction in two downstream molecules in the N-methyl-D-aspartate receptor (NMDAR) pathway (CaMKII and CREB), but neither single treatment did.

"Environmental enrichment and MgT may synergistically improve recognition and spatial memory by reducing synaptic loss and restoring the NMDAR signaling pathway in AD mice, which suggests that combination of EE and MgT may be a novel therapeutic strategy for AD," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »